The analogue was developed with agricultural growth in view before it became a culture reagent

Published 26 October 2026 · REVIVE LAB UAE Research Desk · 5 min read
The IGF-1 analogues from Adelaide came out of a research environment focused on animal production: the Cooperative Research Centre for Tissue Growth and Repair and the state agricultural laboratories, with Ballard, Francis, Wallace and Tomas among the investigators. The early rat work on Long R3 IGF-1 measured nitrogen retention, gut growth and weight gain, endpoints that mattered to livestock science. Veterinary use did not follow, because a protein that must be injected and acts on glucose is impractical and unapprovable in food animals, and the molecule found its market as a serum-free media supplement through the company GroPep, which the group founded.

The research setting

Australian agricultural research in the 1980s and 1990s invested heavily in growth biology, and the IGF system was central. Bovine IGF-1 was purified and sequenced in Adelaide, the binding proteins were characterised, and analogues were designed to test the role of binding proteins in vivo. The rat was the model and growth was the endpoint. The question being asked was how to make animals grow more efficiently.

Human therapeutic development was not the primary aim.

Why not a veterinary product

Regulatory approval for a growth-promoting protein in food animals would have required residue studies, consumer safety data and public acceptance that the era of bovine growth hormone controversy made unlikely. The hypoglycaemic effect and the need for injection made it impractical at farm scale. The analogue was more valuable as a reagent that made cell culture cheaper and more defined.

GroPep supplied it to media manufacturers from the mid-1990s and was later acquired by a larger life-science company.

Why it is here

Because the origin explains both the design of the molecule and the shape of its literature: rats, growth, nitrogen, and then cells. It describes history and no use of the pack.

IGF-1 LR3 is supplied by REVIVE LAB UAE for laboratory research use only, with identity and purity documented for the batch. It is not for human or veterinary use, and no dosing, administration or protocol guidance is provided.

What it costs

FormatStrengthPriceAvailability
IGF-1 LR3 Pack1 mgAED 650In stock

Delivery is AED 40 flat and free on orders over AED 700. Payment is cash on delivery anywhere in the UAE, or USDT (TRC20) in advance, which takes 5% off the order total.

Frequently asked

The research setting?

Australian agricultural research in the 1980s and 1990s invested heavily in growth biology, and the IGF system was central. Bovine IGF-1 was purified and sequenced in Adelaide, the binding proteins were characterised, and analogues were designed to test the role of binding proteins in vivo. The rat was the model and growth was the endpoint. The question being asked was how to make animals grow more efficiently.

Does REVIVE LAB UAE provide dosing guidance?

No. REVIVE LAB UAE supplies research materials and provides no dosing, administration or protocol guidance of any kind. Every product is sold for laboratory research use only and is not for human or veterinary consumption.

How fast is delivery in the UAE?

Stock is held in Dubai. An order confirmed before 4 PM Dubai time is dispatched the same working day, reaching Dubai and Abu Dhabi the same day and the remaining emirates within 24 hours. Delivery is AED 40 flat and free over AED 700.

IGF-1 LR3 Pack — in stock, dispatched from Dubai
HPLC-verified, lot certificate on every carton, 24-hour delivery nationwide. Browse the catalogue → All peptides UAE

Related reading

Supplied for laboratory research use only. Not for human or veterinary consumption. REVIVE LAB UAE provides no dosing, administration or protocol guidance.